Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gopa Iyer

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Journal for Immunotherapy of Cancer|October 5, 2018
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancyMichael Lattanzi, Fang-Ming Deng, Luis A Chiriboga, et al.
Clinical Genitourinary Cancer|February 13, 2021
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 PandemicMichal Sarfaty, Darren R Feldman, Michael J Morris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 3, 2021
Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint InhibitorsJose Mauricio Mota, Min Yuen Teo, Karissa Whiting, et al.
The Oncologist|July 10, 2025
Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case seriesIan Nykaza, Andrea Moy, Stephen W Dusza, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biologyJeffrey S Damrauer, Katherine A Hoadley, David D Chism, et al.
Urologic Oncology|January 26, 2023
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1Patrick J Hensley, Roland Seiler, Harry Herr, et al.
Cancer|August 30, 2012
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancerRachel N Grisham, Gopa Iyer, Karuna Garg, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder CancerAssaf Moore, Stephanie M Lobaugh, Zhigang Zhang, et al.
Clinical Genitourinary Cancer|September 16, 2015
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial CarcinomaPatrizia Pinciroli, Helen Won, Gopa Iyer, et al.
Cancer Metastasis Reviews|April 30, 2026
Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analysesBálint Dér, Melinda Váradi, Nikolett Nagy, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Journal for Immunotherapy of Cancer|October 5, 2018
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancyMichael Lattanzi, Fang-Ming Deng, Luis A Chiriboga, et al.
Clinical Genitourinary Cancer|February 13, 2021
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 PandemicMichal Sarfaty, Darren R Feldman, Michael J Morris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 3, 2021
Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint InhibitorsJose Mauricio Mota, Min Yuen Teo, Karissa Whiting, et al.
The Oncologist|July 10, 2025
Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case seriesIan Nykaza, Andrea Moy, Stephen W Dusza, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biologyJeffrey S Damrauer, Katherine A Hoadley, David D Chism, et al.
Urologic Oncology|January 26, 2023
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1Patrick J Hensley, Roland Seiler, Harry Herr, et al.
Cancer|August 30, 2012
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancerRachel N Grisham, Gopa Iyer, Karuna Garg, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder CancerAssaf Moore, Stephanie M Lobaugh, Zhigang Zhang, et al.
Clinical Genitourinary Cancer|September 16, 2015
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial CarcinomaPatrizia Pinciroli, Helen Won, Gopa Iyer, et al.
Cancer Metastasis Reviews|April 30, 2026
Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analysesBálint Dér, Melinda Váradi, Nikolett Nagy, et al.
Pageof 15